CINA-ASPECTS

by Avicenna.AI  · Based in France → — Medical Innovation for Enhanced Patient Care
Emergency Medicine Neurology Radiology

Subscription-based, contact vendor for details.
Regulatory Status Disclosed

Overview

CINA-ASPECTS is an AI-powered medical imaging software developed by Avicenna.AI, designed for the rapid and automated assessment of acute ischemic stroke from non-contrast CT (NCCT) images. It is part of Avicenna.AI’s CINA Head family of AI tools that support the treatment of stroke and neurovascular emergencies.

The tool automatically processes NCCT scans and calculates the Alberta Stroke Program Early CT Score (ASPECTS), a topographic scoring system used to quantify the severity of a stroke. CINA-ASPECTS assists stroke physicians and radiologists in characterizing early ischemic brain tissue injury, aiming to improve the reproducibility of the ASPECT score, which can often vary among readers.

Beyond providing the ASPECT Score, CINA-ASPECTS generates a heat map indicating the probability of hypodensity and/or sulcal effacement in the brain, outlines and displays infarcted regions, and offers a summary chart with mean Hounsfield Unit (HU) per region. It also provides tilted and re-sliced CT images to facilitate easy comparison of the right and left hemispheres.

CINA-ASPECTS is indicated for use in the analysis of non-enhanced head CT images and for the evaluation of patients presenting with known Middle Cerebral Artery (MCA) or Internal Carotid Artery (ICA) occlusion, to assess the extent of the disease. It is intended to assist trained clinicians, including stroke physicians and radiologists, and is not for primary interpretation of CT images, but rather to aid clinician evaluation in conjunction with other patient information.

The solution integrates seamlessly into existing clinical workflows, automatically triggering and reporting algorithm results through systems already used by radiologists, such as PACS and RIS.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated ASPECT score calculation
  • Heat map indicating probability of hypodensity and/or sulcal effacement
  • Outlines and displays infarcted regions
  • Summary chart with mean Hounsfield Unit (HU) per region
  • Provides tilted and re-sliced CT images for hemisphere comparison
  • Improves inter-reader agreement in ASPECT scoring
  • Reduces interpretation time for clinicians
  • Seamless integration with PACS, RIS, and other hospital systems
  • DICOM 3.0 standard compatibility
  • Computer-aided diagnosis (CADx) functionality

Use Cases

  • Assessment of acute ischemic stroke severity
  • Evaluation of patients with known MCA or ICA occlusion
  • Assisting stroke physicians and radiologists in workflow
  • Enhancing clinical decision-making for stroke treatment
  • Quantifying the extent of early ischemic brain tissue injury
  • Improving reproducibility of ASPECT scores among clinicians

What Physicians Need to Know

Stroke Detection Speed
CINA-ASPECTS provides faster, more consistent, and precise interpretation for acute ischemic stroke assessment. It can process images and deliver results within 10-60 seconds, significantly reducing interpretation time for clinicians.
Brain MRI/CT Analysis
The tool analyzes non-enhanced head CT images, automatically reorienting, segmenting, and analyzing ASPECTS Regions of Interest (ROIs). It generates heat maps indicating the probability of hypodensity and sulcal effacement, outlines infarcted regions, and provides a summary chart with mean Hounsfield Unit per region. It also offers tilt-corrected CT images for easier comparison between hemispheres.
Large Vessel Occlusion Detection
CINA-ASPECTS is indicated for the evaluation of patients presenting with known Middle Cerebral Artery (MCA) or Internal Carotid Artery (ICA) occlusion, assisting in the assessment of the extent of disease.
Triage Prioritization Speed
Developed as a triage tool for emergency radiology, CINA-ASPECTS immediately reports suspected acute intracranial ischemia in CT studies, enabling prioritization of these patients and contributing to rapid triage and workflow optimization.
ASPECTS Score Automation
CINA-ASPECTS automatically processes non-contrast CT scans to calculate the Alberta Stroke Program Early CT Score (ASPECTS). It synthesizes imaging features into a single informative score, provides a summary table, and improves the reproducibility and accuracy of ASPECTS scoring among physicians. It has demonstrated a region-based accuracy of 88.6% and a dichotomized ASPECTS classification accuracy of 80.4%.
Mobile Notification System
Avicenna.AI's tools, including CINA-ASPECTS, are designed to integrate seamlessly into radiologists' clinical workflows, automatically triggering and reporting algorithm results through existing systems. This often includes notifications to care teams for quicker triage.
Physician Tip

CINA-ASPECTS is a valuable AI-powered computer-aided diagnosis (CADx) tool designed to assist clinicians in the rapid and consistent assessment of acute ischemic stroke from non-enhanced head CT images. It enhances decision-making by providing automated ASPECTS scoring, heat maps of hypodensity, and outlining infarcted regions, which can improve inter-reader agreement and reduce interpretation time. It is particularly useful for evaluating the extent of disease in patients with known MCA or ICA occlusions. However, it is crucial to remember that CINA-ASPECTS is an assistive tool and not intended for primary image interpretation or for diagnosing neurological pathologies other than acute stroke. Its use is validated for patients over 21 years old and within 12 hours from the last known well time for ischemia caused by known ICA or MCA occlusions. Always integrate its findings with comprehensive patient information and professional judgment.

CINA-ASPECTS is designed for seamless integration into standard clinical workflows and reading environments, such as PACS. It supports DICOM output and worklist integration. The software is compatible with images acquired from major CT scanner manufacturers including Canon Medical Systems, GE Healthcare, Philips Healthcare, and Siemens Healthineers. It can also be integrated via AI marketplaces or distribution platforms.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Subscription-based, contact vendor for details. — Contact vendor for specific tiers and models.
DeploymentIntegrates natively with PACS, RIS, and other core hospital systems. Can be deployed across a single site or scaled to support complex hospital networks and teleradiology providers. Offers DICOM output and worklist integration.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

CINA-ASPECTS received 510(k) clearance (K233342) from the US FDA on March 15, 2024. It is classified as a computer-aided diagnosis (CADx) software device intended to assist clinicians in the assessment and characterization of brain tissue abnormalities using CT image data, specifically for stroke severity assessment by calculating the ASPECT score.

Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

CINA-ASPECTS by Avicenna.AI is an AI-powered tool designed to assist physicians in assessing the severity of acute ischemic stroke by automatically calculating the Alberta Stroke Program Early CT Score (ASPECTS) from non-contrast CT scans. It aims to improve the accuracy and reproducibility of stroke assessments, which can often vary among radiologists. The tool has received FDA clearance and has been rigorously validated on various CT scanner models.

Overall: Positive

Strengths

  • Automatically calculates the ASPECT score, aiding in stroke severity assessment.
  • Improves clinicians' accuracy in assessing ASPECTS regions compared to conventional methods.
  • Enhances reproducibility of ASPECT scoring among physicians.
  • Provides a heat map indicating probability of hypodensity and sulcal effacement, and displays infarcted regions.
  • Offers CT images corrected for tilt to facilitate comparison between brain hemispheres.
  • Validated on a wide range of CT scanner models from leading manufacturers.

Limitations

  • Not intended for primary interpretation of CT images; it is an assistive tool for physicians.
  • Validated only in patients with known MCA or ICA unilateral occlusion prior to ASPECTS scoring.
  • Not suitable for use on brain scans displaying neurological pathologies other than acute stroke (e.g., tumors, traumatic brain injuries, hemorrhagic transformation).
  • Use in clinical settings other than brain ischemia within 12 hours from time last known well, caused by known ICA or MCA occlusions, has not been tested.
  • Validated and intended for use only in patient populations aged over 21.
  • Only validated with images acquired with Canon Medical Systems Corporation, GE Healthcare, Philips Healthcare, and Siemens Healthineers scanners.

Based on reviews from: Avicenna.AI, BioWorld, Xtalks, PR Newswire, Blackford Analysis, accessdata.fda.gov

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CINA-ASPECTS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

NeuroNews
Avicenna.AI secures US FDA 510(k) clearance for two AI-powered imaging tools
Avicenna.AI received 510(k) clearance from the US FDA for its CINA-ASPECTS and CINA-iPE products in March 2024. CINA-ASPECTS is an AI tool for stroke severity assessment, automatically processing non-contrast CT scans and calculating an Alberta Stroke Program Early CT (ASPECT) score.
2024-03
Avicenna.AI
Avicenna.AI Earns Two FDA Clearances For Stroke Assessment
Avicenna.AI announced FDA 510(k) clearance for CINA-iPE and CINA-ASPECTS on March 26, 2024. CINA-ASPECTS is the company's first FDA-cleared computer-aided diagnosis (CADx) tool, providing severity assessment beyond abnormality identification.
2024-03
PharmExec
FDA Grants 501(k) to Two Avicenna.AI Products | PharmExec
The FDA granted 510(k) clearance for Avicenna.AI's CINA-iPE and CINA-ASPECTS products, designed to be integrated into radiologists' workflows. CINA-ASPECTS uses AI to assess stroke severity from non-contrast CT scans, providing reproducible results.
2024-03
NeuroNews
Viz.ai announces integration of Avicenna.AI's CINA-ASPECTS stroke severity assessment tool - NeuroNews
Viz.ai and Avicenna.AI announced the integration of CINA-iPE and CINA-ASPECTS into Viz.ai's One platform in December 2024. This partnership aims to provide radiologists with enhanced insights from CT scans for faster and more accurate decision-making in stroke and pulmonary embolism cases.
2024-12
Axis Imaging News
FDA OKs Two Avicenna.AI Medical Imaging Tools
Avicenna.AI received U.S. FDA 510(k) clearance for its CINA-iPE and CINA-ASPECTS products, which use deep learning to detect and prioritize life-threatening conditions. CINA-ASPECTS assesses stroke severity by processing non-contrast CT scans and calculating the ASPECT score.
2024-03
Xtalks
Avicenna.AI Gets FDA Clearance for AI-Powered CT Scan Tools for Pulmonary Embolism and Stroke Assessment - Xtalks
Avicenna.AI received FDA 510(k) clearance for CINA-iPE and CINA-ASPECTS, AI tools for pulmonary embolism detection and stroke severity assessment, respectively. CINA-ASPECTS automatically processes non-contrast CT scans to produce an ASPECT score, enhancing reproducibility of stroke assessments.
2024-04
Avicenna.AI Clinical Publications
Deep Learning in Emergency Radiology: Evaluating a Tool for Automated ASPECT Scoring in Acute Ischemic Stroke
This peer-reviewed article, published in Clinical NeuroImaging in 2025, evaluates the CINA-ASPECTS tool for automated ASPECT scoring in acute ischemic stroke, demonstrating its performance in emergency radiology.
2025
PR Newswire
Avicenna.AI lands FDA clearance for AI tool for cervical spine fracture detection
Avicenna.AI received 510(k) clearance from the US FDA for its CINA-CSpine tool in September 2024. CINA-ASPECTS is also mentioned as part of Avicenna.AI's portfolio for stroke severity quantification.
2024-09

Videos

Product demos, reviews, and walkthroughs for CINA-ASPECTS.

View all on YouTube

Frequently Asked Questions

CINA-ASPECTS automatically processes non-enhanced head CT images, calculates the ASPECT score, and provides visual information like heat maps and infarcted regions. It integrates seamlessly into standard reading environments like PACS, automatically triggering analysis after image acquisition and delivering results within 10-60 seconds.
CINA-ASPECTS has received FDA 510(k) clearance in the U.S. and CE Mark certification in Europe, indicating its compliance with medical device regulations. While specific data privacy details are not extensively covered in public snippets, medical device companies are generally expected to adhere to strict healthcare data security and privacy standards.
CINA-ASPECTS is intended to assist, not replace, primary interpretation of CT images by trained clinicians. It has been validated for patients with known MCA or ICA occlusion and is not suitable for scans displaying other neurological pathologies like tumors, traumatic brain injuries, or hemorrhagic transformation. Excessive patient motion leading to artifacts can also render scans technically inadequate for its use.
CINA-ASPECTS has demonstrated high accuracy in automated ASPECT scoring, with studies showing improved clinician accuracy and reduced inter-reader variability when used as an adjunct. Its benefits include faster, more consistent, and precise interpretation of acute ischemic stroke, aiding in quicker decision-making and potentially improving patient outcomes.
Yes, there are other AI tools in the market that offer automated ASPECT scoring, such as Rapid ASPECTS by RapidAI Inc. and E-aspects by Brainomix Ltd. Avicenna.AI, the developer of CINA-ASPECTS, also offers a suite of other AI tools for various medical emergencies.
CINA-ASPECTS is typically offered under a subscription-based pricing model. Specific details on the pricing structure, such as per-scan or institutional licensing, are generally determined by the vendor and its partners.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from Avicenna.AI

CINA
AVICENNA.AI
Neurology AI
CINA is an AI-powered suite of tools developed by Avicenna.AI to enhance the detection and triage of critical conditions in CT scans, aiming to improve diagnostic accuracy and patient outcomes.
CINA CHEST
Avicenna.AI
Cardiology AI
CINA CHEST is an FDA-cleared AI-powered radiological triage and notification software by Avicenna.AI, designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans.
CINA-CSpine
Avicenna.AI
Radiology & Imaging AI
CINA-CSpine by Avicenna.AI is an FDA-cleared AI-powered triage tool for the rapid detection and notification of acute cervical spine fractures on non-enhanced neck CT scans, enhancing diagnostic accuracy and patient care.
CINA-iPE
Avicenna.AI
Radiology & Imaging AI
CINA-iPE is an FDA-cleared AI-powered triage tool from Avicenna.AI that detects unsuspected pulmonary embolisms on CT scans performed for other health conditions, enabling radiologists to initiate early treatment and prevent missed diagnoses.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.